Active-ingredient Dossier
Olanzapine
Active-ingredient Dossier for Olanzapine (atypical antipsychotic). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: ZYPREXA
- Brand: OLANCOR
- Brand: OLANZACOR
- Brand: OLANZAPINE
- Brand: OLANZAPINE ODT-WGR
- Brand: OLANZAPINE RBX
- Therapeutic area: Psychiatry
- Therapeutic area: Neurology
What is
Olanzapine Olanzapine is an atypical antipsychotic.
Australian brands containing
Olanzapine — APO-OLANZAPINE — OLANZAPINE SANDOZ — OLANCOR — OLANZACOR — OLANZAPINE — OLANZAPINE ODT-WGR — OLANZAPINE RBX — OZIN — Pharm-Olanzapine — PRYZEX — TORRENIA ODT — ZYPINE
Therapeutic areas
Olanzapine is registered in neurology (19 brands) and psychiatry (1 brand).
Sponsor landscape
Olanzapine is marketed by nine sponsors: Arrotex Pharmaceuticals, Torrent, Pharmacor, Generic Health, GM Pharma, and Sun Pharma.
PBS and regulatory activity
One brand containing olanzapine has PBS-listed items, with a latest PBS schedule date of 1 May 2026. In the 2014–15 fiscal year, olanzapine generated government expenditure of $65,129,816.02 across 1,001,475 scripts. The latest PBAC outcome for olanzapine was recorded on 1 November 2014. No AusPAR records are on file for olanzapine.